These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34820745)

  • 1. Neural correlates and predictors of subjective cognitive decline in patients with Parkinson's disease.
    Ophey A; Krohm F; Kalbe E; Greuel A; Drzezga A; Tittgemeyer M; Timmermann L; Jessen F; Eggers C; Maier F
    Neurol Sci; 2022 May; 43(5):3153-3163. PubMed ID: 34820745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease.
    Yang N; Ju Y; Ren J; Wang H; Li P; Ning H; Tao J; Liu W
    Acta Neurol Scand; 2022 Sep; 146(3):276-282. PubMed ID: 35722712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
    Dong QY; Li TR; Jiang XY; Wang XN; Han Y; Jiang JH
    Alzheimers Res Ther; 2021 Apr; 13(1):74. PubMed ID: 33827675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic review.
    Oedekoven C; Egeri L; Jessen F; Wagner M; Dodel R
    Ageing Res Rev; 2022 Feb; 74():101508. PubMed ID: 34740867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction.
    Maier F; Greuel A; Hoock M; Kaur R; Tahmasian M; Schwartz F; Csoti I; Jessen F; Drzezga A; van Eimeren T; Timmermann L; Eggers C
    Psychol Med; 2023 Mar; 53(4):1244-1253. PubMed ID: 37010224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
    PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.
    Blum D; la Fougère C; Pilotto A; Maetzler W; Berg D; Reimold M; Liepelt-Scarfone I
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2387-2395. PubMed ID: 30008111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Firbank MJ; Yarnall AJ; Lawson RA; Duncan GW; Khoo TK; Petrides GS; O'Brien JT; Barker RA; Maxwell RJ; Brooks DJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):310-316. PubMed ID: 28315844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic correlates of fatigue in Parkinson's disease: a PET study.
    Zhang L; Li T; Yuan Y; Tong Q; Jiang S; Wang M; Wang J; Ding J; Xu Q; Zhang K
    Int J Neurosci; 2018 Apr; 128(4):330-336. PubMed ID: 28918694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
    J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre-Mild Cognitive Impairment.
    Tondo G; Boccalini C; Vanoli EG; Presotto L; Muscio C; Ciullo V; Banaj N; Piras F; Filippini G; Tiraboschi P; Tagliavini F; Frisoni GB; Cappa SF; Spalletta G; Perani D;
    Neurology; 2022 Jul; 99(3):e258-e269. PubMed ID: 35487700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.